These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22335629)

  • 61. Scar revision via resurfacing.
    Bradley DT; Park SS
    Facial Plast Surg; 2001 Nov; 17(4):253-62. PubMed ID: 11735058
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of argyria using the quality-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser: efficacy and persistence of results at 1-year follow-up.
    Hovenic W; Golda N
    Dermatol Surg; 2012 Dec; 38(12):2031-4. PubMed ID: 22861147
    [No Abstract]   [Full Text] [Related]  

  • 63. Erythema ab igne successfully treated using 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low fluence.
    Cho S; Jung JY; Lee JH
    Dermatol Surg; 2011 Apr; 37(4):551-3. PubMed ID: 21481074
    [No Abstract]   [Full Text] [Related]  

  • 64. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
    Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-pulse neodymium-doped yttrium aluminum garnet laser treatment improves amiodarone-induced hyperpigmentation.
    Bagheri S; Eisen D
    Dermatol Surg; 2011 Oct; 37(10):1539-41. PubMed ID: 21707831
    [No Abstract]   [Full Text] [Related]  

  • 66. Transplantation of autologous cultured melanocytes for treatment of large segmental vitiligo.
    Chen YF; Yang PY; Hung CM; Hu DN
    J Am Acad Dermatol; 2001 Mar; 44(3):543-5. PubMed ID: 11209136
    [No Abstract]   [Full Text] [Related]  

  • 67. Punctate leucoderma after 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy: is it melanocytopenic or melanopenic?
    Kim T; Cho SB; Oh SH
    Dermatol Surg; 2010 Nov; 36(11):1790-1. PubMed ID: 20961356
    [No Abstract]   [Full Text] [Related]  

  • 68. Combination of 595-nm pulsed dye laser, long-pulsed 755-nm alexandrite laser and microdermabrasion treatment for keratosis pilaris.
    Lee SJ; Chung WS; Kim J; Cho SB
    J Dermatol; 2012 May; 39(5):479-80. PubMed ID: 21973291
    [No Abstract]   [Full Text] [Related]  

  • 69. Establishing melanocyte cultures in a serum-free system for transplantation in vitiligo patients.
    Czajkowski R; Placek W; Drewa T; Olszewska-Słonina D; Sir J; Kowaliszyn B; Weiss M
    Med Sci Monit; 2006 Feb; 12(2):CR63-9. PubMed ID: 16449949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vitiligo.
    Falabella R
    Acta Derm Venereol; 1994 Mar; 74(2):147-8. PubMed ID: 7911625
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment of periungual vitiligo with erbium-YAG-laser plus 5-flurouracil: a left to right comparative study.
    Anbar T; Westerhof W; Abdel-Rahman A; El-Khayyat M; El-Metwally Y
    J Cosmet Dermatol; 2006 Jun; 5(2):135-9. PubMed ID: 17173588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Commentary: treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a novel Q-switched neodymium-doped yttrium aluminum garnet laser.
    Metelitsa AI
    Dermatol Surg; 2010 Sep; 36(9):1381. PubMed ID: 20629692
    [No Abstract]   [Full Text] [Related]  

  • 73. Immunohistochemical evaluation of skin before and after micro-ablative fractional erbium-doped yttrium aluminum garnet laser treatment.
    Odo LM; Odo ME; Guedes F; Sotto MN; Carlos Cucé L
    Dermatol Surg; 2011 Feb; 37(2):246-8. PubMed ID: 21324032
    [No Abstract]   [Full Text] [Related]  

  • 74. Granuloma annulare successfully treated using fractional photothermolysis with a 1,550-nm erbium-doped yttrium aluminum garnet fractionated laser.
    Liu A; Hexsel CL; Moy RL; Ozog DM
    Dermatol Surg; 2011 May; 37(5):712-5. PubMed ID: 21457398
    [No Abstract]   [Full Text] [Related]  

  • 75. Transplantation of melanocytes in vitiligo.
    Olsson MJ; Juhlin L
    Br J Dermatol; 1995 Apr; 132(4):587-91. PubMed ID: 7748750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inoculation of a cultured autologous epidermal suspension containing melanocytes in vitiligo.
    Jha AK; Pandey SS; Gulati AK; Bansal V; Shukla VK; Singh G
    Arch Dermatol; 1993 Jun; 129(6):785-6. PubMed ID: 8507087
    [No Abstract]   [Full Text] [Related]  

  • 77. Autografts and cultured epidermis in the treatment of vitiligo.
    Pianigiani E; Andreassi A; Andreassi L
    Clin Dermatol; 2005; 23(4):424-9. PubMed ID: 16023939
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vitiligo: the evolution of cultured epidermal autografts and other surgical treatment modalities.
    Yaar M; Gilchrest BA
    Arch Dermatol; 2001 Mar; 137(3):348-9. PubMed ID: 11255337
    [No Abstract]   [Full Text] [Related]  

  • 79. Dermabrasion of the Eyelids in Vitiligo Surgery.
    Ashique KT; Kaliyadan F; Iqbal S
    Dermatol Surg; 2016 May; 42(5):691-2. PubMed ID: 27089034
    [No Abstract]   [Full Text] [Related]  

  • 80. Use of Suction Blisters for Noncultured Epidermal Suspension Grafting in Patients With Vitiligo.
    Jeong HS; Vandergriff T; Pandya AG
    Dermatol Surg; 2016 May; 42(5):688-91. PubMed ID: 27093580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.